JOHNS HOPKINS UNIVERSITY
🇳🇦Namibia
Psychological Treatments for Scleroderma
Phase 2
Completed
- Conditions
- DepressionSystemic SclerosisPainScleroderma
- Interventions
- Behavioral: Self-help cognitive behavioral intervention facilitated by a psychologistBehavioral: Cognitive behavioral therapyBehavioral: Disease/health education
- First Posted Date
- 2000-12-18
- Last Posted Date
- 2017-08-09
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 89
- Registration Number
- NCT00007267
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
Naltrexone Treatment for Alcoholism
Phase 4
Completed
- Conditions
- Alcoholism
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 192
- Registration Number
- NCT00000438
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
Not Applicable
Completed
- Conditions
- EpilepsyCysticercosis
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 120
- Registration Number
- NCT00004403